Lin Bo-Wen, Gong Cheng-Chen, Song Hai-Fei, Cui Ying-Yu
Department of Regenerative Medicine, Tongji University School of Medicine, Shanghai, China.
Key Laboratory of Arrhythmias, Ministry of Education (Tongji University), Shanghai, China.
Br J Pharmacol. 2017 Jun;174(11):1226-1243. doi: 10.1111/bph.13627. Epub 2016 Oct 25.
Anthocyanins are a class of water-soluble flavonoids, which show a range of pharmacological effects, such as prevention of cardiovascular disease, obesity control and antitumour activity. Their potential antitumour effects are reported to be based on a wide variety of biological activities including antioxidant; anti-inflammation; anti-mutagenesis; induction of differentiation; inhibiting proliferation by modulating signal transduction pathways, inducing cell cycle arrest and stimulating apoptosis or autophagy of cancer cells; anti-invasion; anti-metastasis; reversing drug resistance of cancer cells and increasing their sensitivity to chemotherapy. In this review, the latest progress on the anticancer activities of anthocyanins and the underlying molecular mechanisms is summarized using data from basic research in vitro and in vivo, from clinical trials and taking into account theory and practice.
This article is part of a themed section on Principles of Pharmacological Research of Nutraceuticals. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.11/issuetoc.
花青素是一类水溶性黄酮类化合物,具有一系列药理作用,如预防心血管疾病、控制肥胖和抗肿瘤活性。据报道,它们潜在的抗肿瘤作用基于多种生物学活性,包括抗氧化;抗炎;抗诱变;诱导分化;通过调节信号转导通路抑制增殖、诱导细胞周期停滞以及刺激癌细胞凋亡或自噬;抗侵袭;抗转移;逆转癌细胞的耐药性并增加其对化疗的敏感性。在本综述中,利用体外和体内基础研究、临床试验的数据,并结合理论与实践,总结了花青素抗癌活性及其潜在分子机制的最新进展。
本文是营养保健品药理研究原理主题部分的一部分。要查看本节中的其他文章,请访问http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.11/issuetoc。